肝素诱导的血小板减少症的监测与管理。
Monitoring and management of heparin-induced thrombocytopenia.
作者信息
Rogers Ba, Little Nj, Jones C
机构信息
Trauma and Orthopaedics, St George's Hospital, London, UK.
出版信息
Br J Hosp Med (Lond). 2009 Nov;70(11):630-3. doi: 10.12968/hmed.2009.70.11.45051.
Abstract
Low molecular weight heparins have been used to reduce thromboembolic risk for at least 20 years, but their use is not without risk. This article considers the incidence, monitoring, treatment and lack of insight about heparin-induced thrombocytopenia - a potentially fatal complication of low molecular weight heparin use.
摘要
低分子量肝素已被用于降低血栓栓塞风险至少20年了，但其使用并非毫无风险。本文探讨了肝素诱导的血小板减少症的发生率、监测、治疗以及人们对它缺乏了解的情况——这是使用低分子量肝素可能导致的一种潜在致命并发症。
Zotero 插件